Technetium-99m hexamethylpropylene amine oxime single photon emission tomography of the brain in early Parkinson's disease: correlation with dementia and lateralization

Regional cerebral blood flow was assessed in 19 patients with early idiopathic Parkinson's disease (PD) and 12 control subjects of similar age by single-photon emission tomography using technetium-99m hexamethylpropylene amine oxime (HMPAO). Of the patients with PD, seven were mildly demented and 15 presented with hemiparkinsonism. Mean HMPAO cortical or basal ganglia/cerebellum activity ratios were calculated. Mean cortical and regional uptake ratios in non-demented PD patients were not significantly different from values in the controls. In contrast, besides generalized cortical hypoperfusion, demented PD patients had significantly lower HMPAO uptake in the frontal and basal ganglia regions than non-demented patients. These observations support the hypothesis of impaired neuronal activity in both cortical and subcortical regions of the brain in demented PD patients. In hemiparkinsonian patients, the only asymmetrical finding was a relative hypoperfusion in the contralateral parietal region. This may be due to deafferentation of the thalamoparietal pathways. The lack of asymmetrical uptake in basal ganglia in our PD patients may be explained by their staging at the time of the investigation (stage I and II, Hoehn and Yahr scale).

[1]  M C Bourdel,et al.  (99mTc)-HM-PAO SPECT and cognitive impairment in Parkinson's disease: a comparison with dementia of the Alzheimer type. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[2]  J. Wallet,et al.  Gauged BRST symmetry for the free bosonic string , 1987 .

[3]  J. Rinne,et al.  Brain muscarinic receptor subtypes are differently affected in Alzheimer's disease and Parkinson's disease , 1989, Brain Research.

[4]  A. Bonnet,et al.  [The Unified Parkinson's Disease Rating Scale]. , 2000, Revue neurologique.

[5]  O. Rascol,et al.  Cognition and cerebral blood flow in lateralised parkinsonism: lack of functional lateral asymmetries. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[6]  M E Raichle,et al.  Regional blood flow in hemiparkinsonism. , 1985, Neurology.

[7]  P F Sharp,et al.  Technetium-99m HM-PAO stereoisomers as potential agents for imaging regional cerebral blood flow: human volunteer studies. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  A. Lees,et al.  Cognitive deficits in the early stages of Parkinson's disease. , 1983, Brain : a journal of neurology.

[9]  J. Saint-Cyr,et al.  Frontal lobe dysfunction in Parkinson's disease. The cortical focus of neostriatal outflow. , 1986, Brain : a journal of neurology.

[10]  E. V. van Royen,et al.  Single photon emission computed tomography in Alzheimer's disease. , 1989, Archives of neurology.

[11]  L. Henriksen,et al.  Asymmetric Cerebral Blood Flow in Hemiparkinsonian Patients: Tomography of Inhaled Xenon 133 Before and After Levodopa Treatment , 1985 .

[12]  T. Jones,et al.  Regional impairment of cerebral oxidative metabolism in Parkinson's disease. , 1979, Journal of neurology, neurosurgery, and psychiatry.

[13]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[14]  Y Agid,et al.  Is the mesocortical dopaminergic system involved in Parkinson disease? , 1980, Neurology.

[15]  S. Bentin,et al.  Regional cerebral blood flow in patients with Parkinson's disease. , 1979, Archives of neurology.

[16]  T Jones,et al.  Alterations of regional cerebral blood flow and oxygen metabolism in Parkinson's disease , 1985, Neurology.

[17]  D L Price,et al.  Basal forebrain neurons in the dementia of Parkinson disease , 1983, Annals of neurology.

[18]  C. P. Hughes,et al.  A New Clinical Scale for the Staging of Dementia , 1982, British Journal of Psychiatry.

[19]  R J Wise,et al.  The effects of L-DOPA on regional cerebral blood flow and oxygen metabolism in patients with Parkinson's disease. , 1985, Brain : a journal of neurology.

[20]  R. Mayeux,et al.  Is "subcortical dementia" a recognizable clinical entity? , 1983, Annals of neurology.

[21]  P. Dupui,et al.  Cerebral Blood Flow Studied by Xenon-133 Inhalation Technique in Parkinsonism: Loss of Hyperfrontal Pattern , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[22]  J. Démonet,et al.  Levodopa‐induced regional cerebral blood flow changes in normal volunteers and patients with Parkinson's disease , 1987, Movement disorders : official journal of the Movement Disorder Society.

[23]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[24]  H. Matsuda,et al.  Tc-99m HMPAO brain perfusion tomography atlas using a high resolution SPECT system. , 1990, Clinical nuclear medicine.

[25]  Marcus E. Raichle,et al.  Regional blood flow in herniparkinsonism , 1985, Neurology.

[26]  L. Forno Pathology of Parkinson's disease , 1981 .

[27]  Yves Agid,et al.  A subcortico-cortical cholinergic system is affected in Parkinson's disease , 1983, Brain Research.

[28]  M. Dam,et al.  [99mTc]-HM-PAO SPECT in Parkinson's Disease , 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[29]  Single‐Photon Emission Computed Tomography Findings in Unilateral Parkinsonism , 1991 .

[30]  S. Bentin,et al.  Regional cerebral blood flow in parkinsonism Measurement before and after levodopa , 1978, Journal of Neurological Sciences.

[31]  S. Fahn Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale , 1987 .